LICENSE AGREEMENTLicense Agreement • October 3rd, 2016 • Oxis International Inc • Pharmaceutical preparations • California
THIS LICENSE AGREEMENT (the "Agreement"), effective as of March 10, 2015 (the "Effective Date"), is made by and between Oxis Biotech, Inc., a Delaware corporation, having a place of business at 1407 North Beverly Drive, Beverly Hills, CA 90210 ("OXIS") and MultiCell Immunotherapeutics, Inc., a Delaware corporation, having a place of business at 68 Cumberland Street, Suite 301, Woonsocket, RI 02895 (hereinafter "MCIT").
LICENSE AGREEMENTLicense Agreement • October 3rd, 2016 • Oxis International Inc • Pharmaceutical preparations • California
THIS LICENSE AGREEMENT (the "Agreement") dated as of December 31, 2014 (the "Effective Date"), is entered into between ID4 Pharma, LLC ("ID4"), a having a place of business at 1654 Settlers Drive, Sewickley, PA 15143, and Oxis Biotech, Inc., a Delaware corporation ("Company"), having a place of business at 1402 North Beverly Drive, Beverly Hills, CA 90210 .
LICENSE AGREEMENTLicense Agreement • October 3rd, 2016 • Oxis International Inc • Pharmaceutical preparations • California
THIS LICENSE AGREEMENT (this "Agreement") dated as of September 3, 2015 (the "Effective Date"), is entered into between Daniel A. Vallera, an individual having a place of residence at ____________________________________ , Jeffrey Lion, an individual having a place of residence at ____________________________________ (collectively hereinafter "Licensor"), and Oxis Biotech, Inc., a Delaware corporation ("Company" or "Oxis"), having a place of business at 1402 North Beverly Drive, Beverly Hills, CA 90210 .
NOTE CONVERSION AGREEMENTNote Conversion Agreement • October 3rd, 2016 • Oxis International Inc • Pharmaceutical preparations • Delaware
This Note Conversion Agreement (this "Agreement") is entered into as of January 8, 2016, by and among OXIS International, Inc., a Delaware corporation (the "Company"), and the parties listed on Schedule A hereto.
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • October 3rd, 2016 • Oxis International Inc • Pharmaceutical preparations • Delaware
This Warrant Exercise Agreement (this "Agreement") is entered into as of January 7, 2016, by and among OXIS International, Inc., a Delaware corporation (the "Company"), and the parties listed on Schedule A hereto.
July 12, 2016Letter Agreement • October 3rd, 2016 • Oxis International Inc • Pharmaceutical preparations • New York
PREFERRED STOCK EXCHANGE AGREEMENTPreferred Stock Exchange Agreement • October 3rd, 2016 • Oxis International Inc • Pharmaceutical preparations • Delaware
This Preferred Stock Exchange Agreement (this "Agreement") is entered into as of January 8, 2016, by and among OXIS International, Inc., a Delaware corporation (the "Company"), and the parties listed on Schedule A hereto.
EXCLUSIVE PATENT LICENSE AGREEMENTPatent License Agreement • October 3rd, 2016 • Oxis International Inc • Pharmaceutical preparations • Delaware
THIS EXCLUSIVE PATENT LICENSE AGREEMENT (this "Agreement") is made by and between Regents of the University of Minnesota, a constitutional corporation under the laws of the state of Minnesota, having a place of business at 200 Oak Street, SE, Suite 280, Minneapolis, Minnesota 55455 (the "University"), and the Licensee identified below. The University and the Licensee agree that:
